JP2011527299A5 - - Google Patents

Download PDF

Info

Publication number
JP2011527299A5
JP2011527299A5 JP2011517026A JP2011517026A JP2011527299A5 JP 2011527299 A5 JP2011527299 A5 JP 2011527299A5 JP 2011517026 A JP2011517026 A JP 2011517026A JP 2011517026 A JP2011517026 A JP 2011517026A JP 2011527299 A5 JP2011527299 A5 JP 2011527299A5
Authority
JP
Japan
Prior art keywords
compound
pharmaceutical composition
inhibiting
hcv
hcv replication
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011517026A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011527299A (ja
JP5426671B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2009/004942 external-priority patent/WO2010003658A1/en
Publication of JP2011527299A publication Critical patent/JP2011527299A/ja
Publication of JP2011527299A5 publication Critical patent/JP2011527299A5/ja
Application granted granted Critical
Publication of JP5426671B2 publication Critical patent/JP5426671B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011517026A 2008-07-08 2009-07-08 Ｃ型肝炎ウイルス阻害剤として有用な大環状インドール誘導体 Expired - Fee Related JP5426671B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
EP08159965.6 2008-07-08
EP08159965 2008-07-08
EP08160254 2008-07-11
EP08160254.2 2008-07-11
EP08161743 2008-08-04
EP08161743.3 2008-08-04
PCT/EP2009/004942 WO2010003658A1 (en) 2008-07-08 2009-07-08 Macrocyclic indole derivatives useful as hepatitis c virus inhibitors

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2013176771A Division JP5808370B2 (ja) 2008-07-08 2013-08-28 Ｃ型肝炎ウイルス阻害剤として有用な大環状インドール誘導体

Publications (3)

Publication Number Publication Date
JP2011527299A JP2011527299A (ja) 2011-10-27
JP2011527299A5 true JP2011527299A5 (OSRAM) 2013-10-17
JP5426671B2 JP5426671B2 (ja) 2014-02-26

Family

ID=40972916

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2011517026A Expired - Fee Related JP5426671B2 (ja) 2008-07-08 2009-07-08 Ｃ型肝炎ウイルス阻害剤として有用な大環状インドール誘導体
JP2013176771A Active JP5808370B2 (ja) 2008-07-08 2013-08-28 Ｃ型肝炎ウイルス阻害剤として有用な大環状インドール誘導体

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2013176771A Active JP5808370B2 (ja) 2008-07-08 2013-08-28 Ｃ型肝炎ウイルス阻害剤として有用な大環状インドール誘導体

Country Status (31)

Country Link
US (2) US8921355B2 (OSRAM)
EP (1) EP2310396B1 (OSRAM)
JP (2) JP5426671B2 (OSRAM)
KR (1) KR101640374B1 (OSRAM)
CN (1) CN102089314B (OSRAM)
AP (1) AP2743A (OSRAM)
AR (1) AR072726A1 (OSRAM)
AU (1) AU2009267389B8 (OSRAM)
BR (1) BRPI0915887B8 (OSRAM)
CA (1) CA2729307C (OSRAM)
CL (1) CL2011000032A1 (OSRAM)
CO (1) CO6351793A2 (OSRAM)
CR (1) CR20110076A (OSRAM)
DK (1) DK2310396T3 (OSRAM)
EA (1) EA019008B1 (OSRAM)
EC (1) ECSP11010750A (OSRAM)
ES (1) ES2651038T3 (OSRAM)
HN (1) HN2011000072A (OSRAM)
HR (1) HRP20171892T1 (OSRAM)
HU (1) HUE035244T2 (OSRAM)
IL (1) IL210086A (OSRAM)
LT (1) LT2310396T (OSRAM)
MX (1) MX2011000276A (OSRAM)
NI (1) NI201100010A (OSRAM)
NO (1) NO2310396T3 (OSRAM)
NZ (2) NZ603343A (OSRAM)
SI (1) SI2310396T1 (OSRAM)
SV (1) SV2011003796A (OSRAM)
TW (1) TWI454476B (OSRAM)
UY (1) UY31973A (OSRAM)
WO (1) WO2010003658A1 (OSRAM)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101910177B (zh) 2007-12-24 2013-08-28 泰博特克药品公司 作为丙型肝炎病毒抑制剂的大环吲哚
TWI454476B (zh) * 2008-07-08 2014-10-01 Tibotec Pharm Ltd 用作ｃ型肝炎病毒抑制劑之巨環吲哚衍生物
UA108211C2 (uk) * 2009-11-04 2015-04-10 Янссен Рід Айрленд Бензімідазолімідазольні похідні
EA201291042A1 (ru) * 2010-04-13 2013-03-29 Янссен Фармасьютикалз, Инк. Комбинация макроциклического ингибитора hcv, ненуклеозида и нуклеозида
CN103097356B (zh) * 2010-06-24 2016-01-13 爱尔兰詹森科学公司 13-环己基-3-甲氧基-6-[甲基-(2-{2-[甲基-(氨磺酰基)-氨基]-乙氧基}-乙基)-氨基甲酰基]-7H-吲哚并-[2,1-a]-[2]-苯并氮杂*-10-羧酸的制备
PT2760821T (pt) 2011-09-02 2018-01-11 Novartis Ag Sal de colina de um composto anti-inflamatório de ciclobutenodiona substituída
US8716275B2 (en) * 2011-10-20 2014-05-06 Bristol-Myers Squibb Company Compound for the treatment of hepatitis C
MX2015002684A (es) 2012-08-31 2015-05-12 Janssen Pharmaceuticals Inc Combinacion de un inhibidor macrociclico de proteasas del vhc, un inhibidor del vhc no nucleosidico y ritonavir.
WO2014152275A1 (en) * 2013-03-14 2014-09-25 Concert Pharmaceuticals, Inc. Deuterium modified derivatives of the ns5b polymerase inhibitor tmc647055
US10450263B2 (en) 2017-02-10 2019-10-22 Southern Research Institute Benzo annulenes as antiviral agents
KR101974388B1 (ko) 2017-06-23 2019-05-02 (주)에니켐텍 알킬 디에틸렌 트리아민 유도체 및 이의 제조방법
WO2019133574A2 (en) * 2017-12-26 2019-07-04 Southern Research Institute Benzoannulene derivatives as antiviral agents
US12274700B1 (en) 2020-10-30 2025-04-15 Accencio LLC Methods of treating symptoms of coronavirus infection with RNA polymerase inhibitors
US12060148B2 (en) 2022-08-16 2024-08-13 Honeywell International Inc. Ground resonance detection and warning system and method

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6037157A (en) 1995-06-29 2000-03-14 Abbott Laboratories Method for improving pharmacokinetics
US6054472A (en) * 1996-04-23 2000-04-25 Vertex Pharmaceuticals, Incorporated Inhibitors of IMPDH enzyme
US5807876A (en) * 1996-04-23 1998-09-15 Vertex Pharmaceuticals Incorporated Inhibitors of IMPDH enzyme
US20050267836A1 (en) * 1996-03-25 2005-12-01 Cfph, Llc Method and system for transacting with a trading application
PL192628B1 (pl) 1996-04-23 2006-11-30 Vertex Pharma Pochodne mocznika, kompozycje farmaceutyczne i zastosowanie związku i kompozycji
WO1998040381A1 (en) 1997-03-14 1998-09-17 Vertex Pharmaceuticals Incorporated Inhibitors of impdh enzyme
AU769383B2 (en) * 1999-03-19 2004-01-22 Vertex Pharmaceuticals Incorporated Inhibitors of IMPDH enzyme
WO2002019369A1 (en) 2000-08-30 2002-03-07 Matsushita Electric Industrial Co., Ltd. Plasma display unit and production method thereof
RS51243B (sr) 2004-01-30 2010-12-31 Medivir Ab. Inhibitori ns-3 serina hcv proteaze
US7153848B2 (en) * 2004-08-09 2006-12-26 Bristol-Myers Squibb Company Inhibitors of HCV replication
PE20070211A1 (es) 2005-07-29 2007-05-12 Medivir Ab Compuestos macrociclicos como inhibidores del virus de hepatitis c
CA2620777A1 (en) 2005-09-02 2007-03-08 Tibotec Pharmaceuticals Ltd. Benzodiazepines as hcv inhibitors
US7399758B2 (en) 2005-09-12 2008-07-15 Meanwell Nicholas A Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors
GB0522881D0 (en) 2005-11-10 2005-12-21 Angeletti P Ist Richerche Bio Therapeutic compounds
WO2007092000A1 (en) 2006-02-06 2007-08-16 Bristol-Myers Squibb Company Inhibitors of hcv replication
US7456166B2 (en) * 2006-05-17 2008-11-25 Bristol-Myers Squibb Company Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors
US7521443B2 (en) * 2006-05-17 2009-04-21 Bristol-Myers Squibb Company Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors
US7521441B2 (en) * 2006-05-22 2009-04-21 Bristol-Myers Squibb Company Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors
US7521442B2 (en) * 2006-05-25 2009-04-21 Bristol-Myers Squibb Company Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors
WO2008043704A1 (en) 2006-10-10 2008-04-17 Medivir Ab Hcv nucleoside inhibitor
CN103224506A (zh) * 2006-12-20 2013-07-31 P.安杰莱蒂分子生物学研究所 抗病毒的吲哚
AU2008277442A1 (en) * 2007-07-17 2009-01-22 Istituto Di Ricerche Di Biologia Molecolare P. Angeletti Spa Macrocyclic indole derivatives for the treatment of hepatitis C infections
TWI454476B (zh) * 2008-07-08 2014-10-01 Tibotec Pharm Ltd 用作ｃ型肝炎病毒抑制劑之巨環吲哚衍生物
TW201023858A (en) 2008-09-18 2010-07-01 Ortho Mcneil Janssen Pharm Synergistic combinations of a macrocyclic inhibitor of HCV and a nucleoside
BRPI1008918A2 (pt) 2009-02-27 2016-03-15 Ortho Mcneil Janssen Pharm sal amorfo de um inibidor macrocíclico de hcv
EA201291042A1 (ru) 2010-04-13 2013-03-29 Янссен Фармасьютикалз, Инк. Комбинация макроциклического ингибитора hcv, ненуклеозида и нуклеозида
CN103097356B (zh) 2010-06-24 2016-01-13 爱尔兰詹森科学公司 13-环己基-3-甲氧基-6-[甲基-(2-{2-[甲基-(氨磺酰基)-氨基]-乙氧基}-乙基)-氨基甲酰基]-7H-吲哚并-[2,1-a]-[2]-苯并氮杂*-10-羧酸的制备
MX2015002684A (es) 2012-08-31 2015-05-12 Janssen Pharmaceuticals Inc Combinacion de un inhibidor macrociclico de proteasas del vhc, un inhibidor del vhc no nucleosidico y ritonavir.

Similar Documents

Publication Publication Date Title
JP2011527299A5 (OSRAM)
JP2013518107A5 (OSRAM)
JP2013509429A5 (OSRAM)
JP2009545527A5 (OSRAM)
JP2011518833A5 (OSRAM)
JP2015078230A5 (OSRAM)
JP2014507446A5 (OSRAM)
JP2011105738A5 (OSRAM)
JP2013014622A5 (OSRAM)
JP2010077141A5 (OSRAM)
JP2013525444A5 (OSRAM)
RU2582676C3 (ru) Некоторые химические соединения, композиции и способы
JP2013542247A5 (OSRAM)
JP2012255026A5 (OSRAM)
JP2013032389A5 (OSRAM)
JP2015024998A5 (OSRAM)
JP2009535462A5 (OSRAM)
JP2016503793A5 (OSRAM)
HRP20150725T1 (hr) Kondenzirani imidazolilimidazoli kao antivirusni spojevi
IL195732A (en) Pharmaceutical compounds containing passoterodine, their use and method for their preparation
JP2016515561A5 (OSRAM)
JP2016518337A5 (OSRAM)
JP2014500861A5 (OSRAM)
RU2015149527A (ru) Производные доластатина 10 и ауристатинов
JP2017514910A5 (OSRAM)